Franklin Resources’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Buy
+36,545
New +$1.11M ﹤0.01% 2136
2025
Q1
Sell
-984,063
Closed -$24.4M 3023
2024
Q4
$24.4M Sell
984,063
-65,616
-6% -$1.86M 0.01% 839
2024
Q3
$30.9M Sell
1,049,679
-52,189
-5% -$1.54M 0.01% 747
2024
Q2
$29.1M Buy
1,101,868
+232,652
+27% +$6.62M 0.01% 735
2024
Q1
$28.1M Buy
869,216
+330,119
+61% +$12M 0.01% 756
2023
Q4
$22.7M Buy
+539,097
New +$19.8M 0.01% 724
2023
Q3
Sell
-22,379
Closed -$425K 2729
2023
Q2
$425K Buy
+22,379
New +$417K ﹤0.01% 2040

Other funds holding IMVT

Franklin Resources's IMVT Position: Q2 2026 in Review

Franklin Resources opened a new position in Immunovant (IMVT) in Q2 2026: 36,545 shares worth $1.41M. The stake represents ﹤0.01% of the portfolio and ranks #2136 among its holdings. This is a return to the name: Franklin Resources previously reported a position in IMVT as recently as Q4 2024.

Franklin Resources first reported a position in IMVT in Q2 2023 and has held it in 7 quarters since. The position peaked at $30.9M in Q3 2024. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Franklin Resources held 36,545 shares of Immunovant worth $1.41M as of Q2 2026.
  • Immunovant was a new Franklin Resources position in Q2 2026.
  • Immunovant made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2136 holding.
  • Franklin Resources first reported a position in Immunovant in Q2 2023 and has held it in 7 quarters since.
  • Franklin Resources's Immunovant position peaked at $30.9M in Q3 2024.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.